BAL PHARMA LTD. (BALPHARMA)

Current Price: ₹0.00

Back to Home
Stock Performance

Quarterly Financials

Consolidated Standalone
Particulars Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025
Revenue from Operations 81.97 70.17 92.30 81.49 94.58 73.13 74.70 72.89 81.78 65.64 73.75 87.49
YOY Revenue Growth % 11.13% 0.94% 22.98% 6.44% 15.38% 4.22% -19.07% -10.56% -13.53% -10.25% -1.27% 20.04%
Other Income 0.44 0.45 0.41 0.26 2.23 0.81 0.36 0.82 0.99 0.74 1.13 0.35
Total Income 82.41 70.61 92.71 81.75 96.81 73.94 75.06 73.70 82.77 66.38 74.88 87.84
Total Expenses + 79.10 66.11 81.51 65.93 82.39 63.42 65.13 66.02 79.96 66.05 74.10 85.89
Cost of Materials Consumed 49.72 41.57 50.19 37.92 51.89 36.31 36.13 37.55 39.92 36.03 40.29 43.51
Employee Benefit Expense 13.70 13.20 14.18 14.17 14.56 13.84 14.88 14.81 15.35 14.67 16.15 17.19
Other Expenses 15.68 11.34 17.14 13.84 15.94 13.27 14.12 13.66 14.66 11.33 11.98 14.49
Operating Profit 2.87 4.06 10.79 15.57 12.19 9.71 9.57 6.87 1.82 -0.42 -0.35 1.60
OPM % 3.5% 5.8% 11.7% 19.1% 12.9% 13.3% 12.8% 9.4% 2.2% -0.6% -0.5% 1.8%
Profit Before Tax + 3.21 1.53 2.23 1.67 6.67 2.11 1.53 1.20 2.81 0.32 0.78 1.95
Tax Expense 1.09 0.34 0.63 0.42 0.45 0.36 0.32 0.05 -2.79 0.00 0.00 0.00
Tax % 33.9% 21.9% 28.2% 24.9% 6.8% 17% 20.8% 4% -99.3% 0% 0% 0%
Profit After Tax 2.12 1.20 1.60 1.26 6.22 1.75 1.21 1.16 5.61 0.32 0.78 1.95
EPS (Basic) 1.35 0.76 1.02 0.80 4.16 1.11 0.76 0.73 3.51 0.20 0.49 1.22

Yearly Financial Results

Consolidated Standalone
Particulars Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2018
Revenue from Operations 302.50 338.54 303.10 280.37 249.31 170.67 209.85
YOY Revenue Growth % -10.65% 11.69% 8.11% 12.46% 46.07% -18.67% -
Other Income 2.15 3.35 2.15 6.49 2.70 3.62 1.64
Total Income 304.65 341.89 305.25 286.86 252.01 174.29 211.49
Total Expenses + 298.91 295.93 283.58 253.61 207.88 159.14 191.36
Cost of Materials Consumed 149.89 181.57 176.45 162.95 135.47 79.44 104.92
Employee Benefit Expense 61.83 56.11 51.91 44.46 39.62 48.77 44.63
Other Expenses 52.82 58.25 55.22 46.21 32.79 30.93 41.81
Operating Profit 3.58 42.61 19.52 26.75 41.43 11.53 18.49
OPM % 1.2% 12.6% 6.4% 9.5% 16.6% 6.8% 8.8%
Profit Before Exceptional 5.73 12.11 8.55 12.06 9.80 -9.57 8.45
Exceptional Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Profit Before Tax + 5.73 12.11 8.55 12.06 9.80 -9.57 8.45
Tax Expense -2.07 1.83 2.42 3.48 0.70 -0.04 2.52
Tax % -36.1% 15.1% 28.3% 28.9% 7.1% - 29.8%
Profit After Tax 7.80 10.27 6.13 8.57 9.10 -9.53 5.94
EPS (Basic) 4.89 6.72 3.90 5.79 6.41 -13.44 7.96

Balance Sheet

Particulars Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2018
ASSETS
Non-Current Assets + 102.91 80.16 77.75 0.00 0.00 0.00 0.00
Property, Plant & Equipment 70.95 53.18 52.62 0.00 0.00 0.00 0.00
Capital Work in Progress 2.79 0.47 0.00 0.00 0.00 0.00 0.00
Non-Current Investments 2.16 9.58 0.00 0.00 0.00 0.00 0.00
Goodwill 3.83 0.00 0.00 0.00 0.00 0.00 0.00
Other Intangible Assets 12.00 11.38 10.45 0.00 0.00 0.00 0.00
Current Assets + 247.65 281.14 269.95 0.00 0.00 0.00 0.00
Inventories 102.78 87.49 97.69 0.00 0.00 0.00 0.00
Trade Receivables 94.85 103.10 94.84 0.00 0.00 0.00 0.00
Cash and Cash Equivalents 1.64 4.04 1.23 0.00 0.00 0.00 0.00
Current Investments 2.47 6.76 0.00 0.00 0.00 0.00 0.00
LIABILITIES & EQUITY
Total Equity 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Equity Share Capital 15.92 15.80 15.69 0.00 0.00 0.00 0.00
Other Equity 82.90 89.78 80.34 0.00 0.00 0.00 0.00
Non-Current Liabilities 38.28 46.56 39.52 0.00 0.00 0.00 0.00
Current Liabilities 213.46 209.16 212.15 0.00 0.00 0.00 0.00
Total Liabilities 251.74 255.72 251.67 0.00 0.00 0.00 0.00

Cash Flow Statement

Particulars Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2018
Cash from Operating Activities 20.31 33.35 -8.50 18.42 0.00 0.00 0.00
Cash from Investing Activities -14.90 2.57 -17.95 30.76 0.00 0.00 0.00
Cash from Financing Activities -7.83 24.21 0.00 0.00 0.00 0.00 0.00
Net Increase/Decrease in Cash -2.42 60.13 -26.45 49.18 0.00 0.00 0.00